UBS Group
HCACR

UBS Group’s Hall Chadwick Acquisition Corp Rights HCACR Stock Holding History

UBS Group’s Portfolio HCACR Stock Details HCACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145 Buy
+501
New +$155 ﹤0.01% 10061

Other funds holding HCACR

HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return

UBS Group's HCACR Position: Q2 2026 in Review

UBS Group opened a new position in Hall Chadwick Acquisition Corp Rights (HCACR) in Q2 2026: 501 shares worth $145. The stake represents ﹤0.01% of the portfolio and ranks #10061 among its holdings.

47 funds tracked by Wall St. Rank hold HCACR as of Q2 2026.

  • UBS Group held 501 shares of Hall Chadwick Acquisition Corp Rights worth $145 as of Q2 2026.
  • Hall Chadwick Acquisition Corp Rights was a new UBS Group position in Q2 2026.
  • Hall Chadwick Acquisition Corp Rights made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10061 holding.
  • 47 funds tracked by Wall St. Rank held Hall Chadwick Acquisition Corp Rights as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.